Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago
146last 24h
877last 7d
147● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings108M&A126Regulatory21Product21Analyst17
✕ clear all filtersticker: ^GSPCsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Guardant Health (GH) Surges on FDA Approval and Cancer Screening Momentum
Insider Monkey38d agobullish
Guardant Health (GH) Surges on FDA Approval and Cancer Screening Momentum

Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 14.69% in the second quarter of 2026, slightly trailing the 15.20% gain of the S&P 500 Index as market performance remained highly concentrated in artificial intelligence (AI)-related […]

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC
Insider Monkey89d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]